...
首页> 外文期刊>American Journal of Physiology >Endogenous nitric oxide enhances coupling between O2 consumption and ATP synthesis in guinea pig hearts.
【24h】

Endogenous nitric oxide enhances coupling between O2 consumption and ATP synthesis in guinea pig hearts.

机译:内源性一氧化氮增强了豚鼠心脏中O2消耗与ATP合成之间的耦合。

获取原文
获取原文并翻译 | 示例

摘要

Endogenous nitric oxide (eNO) modulates tissue respiration. To test whether eNO modulates myocardial O2 consumption (MVO2), ATP synthesis, and metabolic efficiency, we used isolated isovolumic guinea pig hearts perfused at a constant flow. N(omega)-nitro-L-arginine (L-NNA; 5 x 10(-5) mol/l) was used to inhibit eNO production. MVO2 was measured at different levels of cardiac work, estimated as the rate-pressure product (RPP). ATP content and synthesis rate were determined using (31)P NMR and magnetization transfer during high cardiac work. L-NNA increased coronary vascular resistance (19 +/- 3%, P < 0.05) and MVO2 (12 +/- 3%, P < 0.05) without an increase in the RPP. In contrast, vehicle infusion resulted in insignificant changes in coronary vascular resistance (3 +/- 2%, P > 0.05) and MVO2 (-2 +/- 1%, P > 0.05). Compared with vehicle, L-NNA caused a higher MVO2 both during KCl arrest (L-NNA 5.6 +/- 0.5 vs. vehicle 3.0 +/- 0.4 micromol x min(-1) x mg x dry wt(-1), P < 0.05) and during increased cardiac work elicited by elevating perfusate Ca2+, indicating an upward shift in the relationship between contractile performance (measured as RPP) and MVO2. However, neither ATP contents nor ATP synthesis rates were different in the two groups during high cardiac work. Thus, because inhibition of eNO production by L-NNA increased MVO2 without a change in the ATP synthesis rate, these data suggest that eNO increases myocardial metabolic efficiency by reducing MVO2 in the heart.
机译:内源性一氧化氮(eNO)调节组织呼吸。为了测试eNO是否调节心肌O2消耗(MVO2),ATP合成和代谢效率,我们使用了以恒定流量灌注的分离的等容豚鼠心脏。使用N(ω)-硝基-L-精氨酸(L-NNA; 5 x 10(-5)mol / l)抑制eNO的产生。在不同的心脏功水平下测量MVO2,估计为心率压积(RPP)。在高心脏工作期间,使用(31)P NMR和磁化强度确定ATP含量和合成速率。 L-NNA增加了冠状​​血管阻力(19 +/- 3%,P <0.05)和MVO2(12 +/- 3%,P <0.05)而RPP没有增加。相反,输注媒介物导致冠状血管阻力(3 +/- 2%,P> 0.05)和MVO2(-2 +/- 1%,P> 0.05)的变化不明显。与媒介物相比,L-NNA在KCl逮捕期间均引起较高的MVO2(L-NNA 5.6 +/- 0.5与媒介物3.0 +/- 0.4 micromol x min(-1)x mg x干wt(-1),P <0.05)并通过增加灌注液Ca2 +引起的心脏工作增加,表明收缩性能(以RPP衡量)和MVO2之间的关系出现了上移。然而,在高心脏工作期间,两组的ATP含量和ATP合成速率均没有差异。因此,由于L-NNA对eNO产生的抑制作用增加了MVO2而不改变ATP合成速率,因此这些数据表明eNO通过减少心脏中的MVO2来增加心肌代谢效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号